治療方案

Viartril®-S維固力™

結晶型硫酸鹽葡萄糖胺 – 骨科醫生推薦No.1 藥物*

紓緩關節痛1–3

Viartril®-S維固力™（通用名稱：結晶型硫酸鹽葡萄糖胺crystalline glucosamine sulphate）由意大利一所大學the University of Pavia的藥理教授Prof Luigi Rovati研發製造，能靈活關節、紓緩痛楚、延緩惡化和修復軟骨。1–9

為何選擇Viartril®-S維固力™

維固力™在香港衛生署註冊，擁有40年歷史，紓緩關節疼痛的療效不但遠比傳統止痛藥（撲熱息痛）較佳，亦可改善關節活動功能。6,10

由於結晶型葡萄糖胺的配方較為穩定，更易被人體吸收， 4維固力™是骨科醫生推薦No.1品牌*。

*根據kantar hong kong於2019對40位註冊私家骨科醫生的訪問結果

國際指引建議

Viartril®-S維固力™（crystalline glucosamine sulphate）為歐洲醫學權威ESCEO（European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthristis and Musculoskeletal Diseases）推薦的一線藥物之一。6,11

  • 參考資料PM-COR-22-112808

    1. Viartril®-S (crystalline glucosamine sulphate) 250 mg & 500 mg Capsules Package Insert. Viatris Healthcare Hong Kong: Version L1086D.
    2. Viartril®-S (crystalline glucosamine sulphate) 1500 mg Sachets Package Insert. Viatris Healthcare Hong Kong: Version L1019F.
    3. Eriksen P, Bartels EM, Altman RD, Bliddal H, Juhl C, Christensen R. Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken). 2014;66(12):1844-1855.
    4. Kucharz EJ, Kovalenko V, Szanto S, Bruyere O, Cooper C, Reginster JY. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin. 2016;32(6):997-1004.
    5. Sun Y, Wang C, Gong C. Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis. J Orthop Surg Res. 2020;15(1):150.
    6. Bruyere O, Altman RD, Reginster JY. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S12-S17.
    7. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage. 2008;16(2):254-260.
    8. Pharmaceutically active glucosamine salts useful in the treatment of osteoarthritis and rheumatoid arthritis (US3683076A). Google Patents. 1972. Available at: https://patents.google.com/patent/US3683076A/en. Accessed on February 13, 2023.
    9. Professor Luigi Rovati. Fondazione Luigi Rovati. Available at: https://fondazioneluigirovati.org/en/professor-luigi-rovati/. Accessed on February 13, 2023.
    10. Viartril®-S capsules 314 mg registration. Hong Kong Department of Health. 2021. Available at: https://www.drugoffice.gov.hk/eps/drug/productDetail2/en/consumer/136855. Accessed on February 13, 2023.
    11. Bruyere O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3-S11.

相關疾病

痛症

了解更多 ...